Visit the Decision Tree website: decision tree
Decision Tree Basics
The decision tree was developed to be used by the responsible clinician in conjunction with flow measurements using the Oesophageal Doppler Monitor (ODM+). A good understanding of cardiovascular physiology is essential, including preload, afterload and contractility. It is essential to ensure the Doppler probe is optimally focused before analysing the data.
At the heart of TrueVue System is Deltex’s ODM+ technology. This is an extremely precise, yet relatively non-invasive system for measuring cardiac output. ODM+ provides a rational approach to using Doppler flow-based measurements to guide therapy.
The Decision Tree is the result of a review of the available evidence by an expert panel of senior clinicians. Importantly it considers patients in both peri-operative and critical care settings.
Oesophageal Doppler monitoring was initially developed as a less invasive alternative to the pulmonary artery catheter. However, from its early inception developers recognised the technology’s is unique potential to drive flow-based treatment algorithms. Doppler-guided fluid management protocols have been proven to improve outcomes in a variety of patient groups.
Several clinical outcome studies have shown Doppler-guided stroke volume optimisation to be beneficial to patients. It is also clear that both excessive fluid volumes and inadequate volume are extremely detrimental to patient outcome. The decision tree is a consolidation of this evidence base and a useful guide to the use of vasoactive and inotropic interventions as part of a global haemodynamic protocol.
Using the Decision Tree
Navigation is simple, featuring a series of Yes/No boxes. Commands are in blue boxes and questions are in grey boxes. Please note that caveats may lead to an alternative pathway. Caveats are in a red box with red pathways. Caveats should be ignored if inappropriate to the patient.
A good understanding of cardiovascular physiology is important. Furthermore it is important that the operator attains optimal focus before interpretation of data.
Trigger Points and Concerns
Find here some of the parameters that the responsible clinician should pay attention to. However, and importantly, NOTE that these trigger points and concerns:
- Should not be assessed in isolation.
- Are not the same as physiological targets
- Are indicative and not absolute
- Are not prioritised
Primary Clinical Indicators
- Hypotension: e.g. Systolic < 100 mmHg, MAP < 60 -70 mmHg or a clinically significant drop in MAP – e.g. 30 – 40 mmHg from assumed ‘normal’ or baseline
- Tachycardia: e.g. > 90 bpm
- Oliguria: < 0.5 ml/kg/h
- Low Cardiac Output State
- Reduced FTc: < 330 ms or considered low for clinical condition e.g. any high resistant state
- Low Cardiac Output: significantly below ‘normal’ e.g. CO < 4– 6 L, CI < 2.5 L/min/m²
- Low Stroke Volume: significantly below ‘normal’ e.g. SV < 50 – 70 ml, SVI < 30 ml
Supplementary Clinical Indicators
- Hypertension: e.g. Systolic > 180 mmHg or > 30 – 40 mmHg above baseline
- Lactate: > 2 mmol/L
- Base Excess: -3 or +3 mEq/L
- Peripheral Shutdown: – Looks ‘unwell’ e.g. pale, sweaty or a clinical picture of poor perfusion
- SaO2: < 93% or having to increase FiO2 by 20% to maintain sats.
- Low ScVO2: < 65 – 70%
- Reduced Consciousness Level: any deterioration rather than a score
For further information please contact us.